Table 2.
Specific antibody | Human epilepsies in which the specific antibody is found | In vitro | In vivo induction of epilepsy | |
---|---|---|---|---|
Antibodies to proteins associated with voltage-gated potassium channels | Anti-leucine-rich glioma inactivated 1 (LGI1) Anti-contactin-associated protein 2 Anti-contactin-2 |
Limbic encephalitis (24, 27, 40, 132) Epileptic encephalopathy (12, 26, 46) Focal epilepsy (133) Human autosomal-dominant lateral temporal lobe epilepsy (32, 36, 37) |
Acute neuronal cell death and loss (may be caused by complementary-mediated mechanisms) (29) | Yes, in rats with heterozygous LGI1 mutation (51) |
Antibodies to ion channels and receptors | Anti-NMDA receptor | Anti-N-methyl-d-aspartate receptor encephalitis (80, 88) | A selective and reversible internalization of surface receptors in cultured neurons (80) | Yes, in mice infused with continuous patients’ cerebrospinal fluid (80) |
Anti-AMPA receptor | Anti-AMPAR encephalitis (102, 103) | Degradation of surface AMPAR clusters (47, 103) | \ | |
Anti-GABAA receptors | Encephalitis (106–108) | Selective reduction of synaptic GABAA receptors (may also be in the way of crosslinking and internalization) (109) | \ |